Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats

Metabolic Aspects of Anthracycline Cardiotoxicity

(2021) Michele Russo et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Heart Failure With Preserved Ejection Fraction In Perspective

(2019) Marc A. Pfeffer et al.   CIRCULATION RESEARCH

Biomarkers in heart failure: the past, current and future

(2019) Michael Sarhene et al.   HEART FAILURE REVIEWS

Cardiovascular variability and β-ARs gene expression at two stages of doxorubicin – Induced cardiomyopathy

(2018) Marko Vasić et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats

(2017) Hoay Yan Cheah et al.   Nanotoxicology

Sudden death: Neurogenic causes, prediction and prevention

(2017) Nina Japundžić-Žigon et al.   European Journal of Preventive Cardiology

From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview

(2017) Carlo Gabriele Tocchetti et al.   ANTIOXIDANTS & REDOX SIGNALING

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury

(2016) Takaaki Yamada et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Targeted myocardial gene expression in failing hearts by RNA sequencing

(2016) Kajari Dhar et al.   Journal of Translational Medicine

Over-expression of V1A receptors in PVN modulates autonomic cardiovascular control

(2016) Maja Lozić et al.   PHARMACOLOGICAL RESEARCH

Drug-induced mitochondrial dysfunction and cardiotoxicity

(2015) Zoltán V Varga et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction

(2015) Sara Tannenbaum et al.   CURRENT OPINION IN CARDIOLOGY

Heart rate dynamics in doxorubicin-induced cardiomyopathy

(2015) T Lončar-Turukalo et al.   PHYSIOLOGICAL MEASUREMENT

Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats

(2014) Maja Lozić et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis

(2013) Josephine A. Grace et al.   GASTROENTEROLOGY

Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury

(2012) Takaaki Yamada et al.   FREE RADICAL BIOLOGY AND MEDICINE

Autonomic mechanisms underpinning the stress response in borderline hypertensive rats

(2011) Olivera Šarenac et al.   EXPERIMENTAL PHYSIOLOGY

Visualizing non-metric similarities in multiple maps

(2011) Laurens van der Maaten et al.   MACHINE LEARNING

Renal Vulnerability to Drug Toxicity

(2009) M. A. Perazella   Clinical Journal of the American Society of Nephrology

Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats

(2008) S. Stojičić et al.   NEUROPHARMACOLOGY